| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |